Ticker >

Oxygenta Pharma share price

Oxygenta Pharmaceutical Ltd.

BSE: 524636 SECTOR: Pharmaceuticals & Drugs  6249   2   0

41.48
0 0
BSE: 12 Apr 04:01 PM

Price Summary

Today's High

₹ 41.48

Today's Low

₹ 41.48

52 Week High

₹ 52.27

52 Week Low

₹ 25.02

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

138.89 Cr.

Enterprise Value

206.78 Cr.

No. of Shares

3.35 Cr.

P/E

0

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  -8.59

CASH

0.11 Cr.

DEBT

67.99 Cr.

Promoter Holding

29.73 %

EPS (TTM)

₹  -4.71

Sales Growth

-48.8%

ROE

0 %

ROCE

-50.31%

Profit Growth

-1795.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-48.8%
3 Year31.21%
5 Year19.21%

Profit Growth

1 Year-1795.44%
3 Year-90.46%
5 Year-188.9%

ROE%

1 Year0%
3 Year0%
5 Year0%

ROCE %

1 Year-50.31%
3 Year-15.71%
5 Year-9.43%

Debt/Equity

-1.4717

Price to Cash Flow

-85.02

Interest Cover Ratio

-6.6453012183615

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 29.73 0
Sep 2023 29.73 0
Jun 2023 26.8 0
Mar 2023 8.99 0
Dec 2022 12.33 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 31.2139559206853% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -53.9672864947549 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 14.5641409275883.

 Limitations

  • The company has shown a poor profit growth of -90.4567356186168% for the Past 3 years.
  • Company has a poor ROE of 0% over the past 3 years.
  • Company has a poor ROCE of -15.7105455980571% over the past 3 years
  • Company has negative cash flow from operations of -1.6336624.
  • The company has a low EBITDA margin of -16.0918205711353% over the past 5 years.
  • The company has negative book value.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 7.87 8.19 6.86 13.08 9.18
Total Expenditure 10.18 10.43 10.5 15.05 11.62
Operating Profit -2.31 -2.25 -3.64 -1.98 -2.44
Other Income 0 0 0 0 0
Interest 0.2 0.94 0.29 0.34 0.36
Depreciation 0.4 0.85 0.5 0.83 0.69
Exceptional Items -0.34 -0.05 -0.13 -0.03 -0.05
Profit Before Tax -3.25 -4.09 -4.56 -3.18 -3.55
Tax 0 0.2 0 -0.02 0.23
Profit After Tax -3.25 -4.29 -4.56 -3.16 -3.78
Adjusted EPS (Rs) -2.29 -3.02 -1.36 -0.94 -1.13

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 20.51 13.72 52.03 60.52 30.99
Total Expenditure 22.55 21.58 48.18 59.05 38.1
Operating Profit -2.04 -7.87 3.84 1.48 -7.12
Other Income 0.31 0.03 0.09 0 0.02
Interest 0.75 1.09 1.78 0.92 1.49
Depreciation 1.02 1 1.2 1.59 2.05
Exceptional Items 0 3.99 2.19 0.55 -0.73
Profit Before Tax -3.49 -5.94 3.14 -0.49 -11.37
Tax -0.24 -0.15 0.21 0.12 0.2
Net Profit -3.25 -5.79 2.93 -0.61 -11.57
Adjusted EPS (Rs.) -3.19 -5.67 2.87 -0.43 -8.15

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 10.2 10.2 10.2 14.2 14.2
Total Reserves -45.36 -51.15 -48.22 -48.83 -60.4
Borrowings 20.87 25.44 45.04 51.04 63.02
Other N/C liabilities 18.72 18.28 9.35 6.69 7.63
Current liabilities 16.73 15.85 17.5 8.07 29.82
Total Liabilities 21.16 18.62 33.86 31.18 54.26
Assets
Net Block 11.9 11.42 16.31 19.98 27.91
Capital WIP 0 0 0.65 0.34 0
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.05 0.05 0.05
Loans & Advances 0.41 0.38 0.91 1.24 1.3
Other N/C Assets 0 0 0 0 0
Current Assets 8.8 6.77 15.94 9.56 25.01
Total Assets 21.16 18.62 33.86 31.18 54.26
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations -3.49 -5.94 3.14 -0.49 -11.37
Adjustment 1.75 2.07 2.96 2.51 3.53
Changes in Assets & Liabilities -6.29 1.13 -7.51 -3.58 6.4
Tax Paid 0.24 0.15 -0.21 -0.12 -0.2
Operating Cash Flow -7.79 -2.59 -1.62 -1.68 -1.63
Investing Cash Flow -0.56 -0.5 -6.72 -4.94 -9.64
Financing Cash Flow 8.36 3.19 8.67 6.33 11.22
Net Cash Flow 0.01 0.1 0.33 -0.29 -0.05

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 12.33 8.99 26.80 29.73 29.73
aakanksha m chawda - - 4.73 4.73 4.73
jhansi rani vankineni 0.18 0.18 0.08 0.08 0.08
k. raghavender rao - - 2.39 2.39 2.39
manoj sunil chawda - - 4.73 4.73 4.73
sadasiva reddy devagudi 0.59 0.59 0.25 0.25 0.25
sai sudhakar vankineni 1.62 1.62 0.69 0.69 0.69
snigdha vankineni 6.11 6.11 3.41 3.41 3.41
sumanth simha vankineni 0.48 0.48 1.03 1.03 1.03
sunil vishram chawda - - 9.50 12.43 12.43
gowtham reddy v 1.06 - - - -
santha vangumalli 0.15 - - - -
sindhuri vongumalli 1.06 - - - -
v n sunanda reddy 1.07 - - - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 87.67 91.01 73.20 70.27 70.27
b subba reddy - - 1.40 1.40 1.40
hemanth kumar kowdi 3.52 3.52 1.49 1.49 1.49
kishore babu bathula - 3.52 1.49 1.49 1.49
pushpalatha vustala - - - 8.96 8.96
qemiq pharma private limi... - - - - 11.80
sanagari kondal reddy - - - 1.49 1.49
sandeep kumar reddy kommi... - - - 8.23 8.23
sravani reddy gantla - - 13.40 13.40 13.40
srivani junoothula - 2.68 1.13 1.13 1.13
subba reddy bhimavarapu 10.79 - - 4.58 4.58
arr capital investment pr... 24.65 24.65 10.45 11.35 -
k. sandeep kumar reddy - - 8.23 - -
popuri ankineedu - - 1.43 - -
s kondal reddy - - 1.49 - -
sudharani popuri - - 1.49 - -
vustala pushpalatha - - 8.96 - -
b subba reddy . 3.29 3.29 - - -
devabhaktuni vidyasagar - 1.18 - - -
durga mahidhar uppalapati... 1.06 1.06 - - -
gowtham reddy v - 1.06 - - -
popuri ankineedu . 7.04 3.38 - - -
sindhuri vongumalli - 1.06 - - -
sudharani popuri . 7.04 3.52 - - -
v n sunanda reddy - 1.07 - - -
viswanadh kandula 1.41 1.41 - - -
vidya sagar devabhaktuni 1.18 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Oxygenta Pharma Stock Price Analysis and Quick Research Report. Is Oxygenta Pharma an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Oxygenta Pharma and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Oxygenta Pharma cash from the operating activity was Rs -1.6336624 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Oxygenta Pharma has a Debt to Equity ratio of -1.4717 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Oxygenta Pharma , the EPS growth was -1795.27797162131 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Oxygenta Pharma has OPM of -22.9668246122174 % which is a bad sign for profitability.
     
  • ROE: Oxygenta Pharma have a poor ROE of 0 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Oxygenta Pharma is Rs 41.48. One can use valuation calculators of ticker to know if Oxygenta Pharma share price is undervalued or overvalued.
Last Updated on:
Brief about Oxygenta Pharma
X